Related Experiment Videos
Mouse erythrocyte formation. A marker for resting B lymphocytes
American Journal of Clinical Pathology
|February 1, 1982
Summary
Only B lymphocytes form mouse rosettes (MR), a characteristic observed in resting B cells. This ability is lost upon activation and is increased in chronic lymphocytic leukemia, indicating a specific role in B cell maturation.
Area of Science:
- Immunology
- Cell Biology
Background:
- Peripheral blood lymphocytes play crucial roles in immune responses.
- B lymphocytes are key components of the adaptive immune system, responsible for antibody production.
- Understanding B cell surface markers and their functions is vital for diagnosing and treating lymphoproliferative disorders.
Purpose of the Study:
- To investigate the ability of peripheral blood lymphocytes to form rosettes with mouse erythrocytes.
- To determine which lymphocyte subset is responsible for mouse rosette (MR) formation.
- To explore the diagnostic potential of MR formation in lymphoproliferative disorders and its relation to B cell maturation stages.
Main Methods:
- Lymphocytes from healthy individuals of various ages and patients with lymphoproliferative disorders were incubated with mouse erythrocytes.
- The percentage of lymphocytes forming mouse rosettes (MR) was quantified.
- The effect of pokeweed mitogen on MR formation in B lymphocytes was assessed.
Main Results:
- Only B lymphocytes demonstrated the ability to form mouse rosettes (MR).
- The percentage of MR showed minor variations based on mouse erythrocyte strain but little variation across age groups in healthy individuals.
- Neoplastic lymphocytes from chronic lymphocytic leukemia patients exhibited an increased number of MR.
- Peripheral blood B lymphocytes lost their MR-forming ability after incubation with pokeweed mitogen.
Conclusions:
- Mouse rosette (MR) formation is a specific marker for resting B lymphocytes.
- The determinant for MR formation is present only at a resting stage of B cell maturation.
- MR formation could serve as a potential diagnostic indicator for certain B cell malignancies, particularly chronic lymphocytic leukemia.